로딩 중…
지수 로딩 중…
YUNGJIN PHARM. CO., LTD
003520· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩1,202-4.22%
2026-06-19
Price Chart
YUNGJIN PHARM. CO., LTD-46.34%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 219.84B KRW |
| Revenue | 253.94B KRW |
| Net Income | -375.7M KRW |
| Total Assets | 233.82B KRW |
| Net Assets | 88.81B KRW |
| Employees | 628 |
| Value | |
| P/B | 2.48x |
| P/S | 0.87x |
| FCF Yield | 0.25% |
| Profitability | |
| ROE | -0.42% |
| ROA | -0.16% |
| Op. Margin | -2.15% |
| Revenue Growth | -0.49% |
| Earnings Growth | -333.74% |
| Financial Health | |
| Debt Ratio | 263.28% |
| Total Debt | 83.87B KRW |
| FCF | 545.9M KRW |
| Cash | 6.27B KRW |
| Current Ratio | 1.66x |
| Performance | |
| 1Y Return | -46.34% |
| 1M Return | -18.45% |
| From 52W High | -50.94% |
| 1Y MDD | -49.07% |
| Trading | |
| Volume | 439,467 shares |
| Foreign Own. | 2.94% |
| Per Share | |
| EPS | -19 KRW |
| BPS | 486 KRW |
Company Info
Youngjin Pharm was established in 1962 for pharmaceutical manufacturing and sales, and listed in 1973, playing a pivotal role as an affiliate of the KT&G Group. The company sells specialty pharmaceuticals such as 'Harmonylan' and 'Fivero', exports antibiotics and raw materials, and aims to strengthen its competitiveness in domestic and international markets. Youngjin Pharm secures growth engines through R&D investment and leads fair and transparent ethical management via a self-compliance program and ISO37001 certification. Its headquarters are in Songpa-gu, Seoul Metropolitan City.